Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 901 AL 915

Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions

Gonzales KK, Smith Y.

Ann N Y Acad Sci. 2015 Sep;1349(1):1-45. doi: 10.1111/nyas.12762. Epub 2015 Apr 15.

Rotigotine transdermal system as add-on to oral dopamine agonist in advanced Parkinson's disease: an open-label study

Kim JM, Chung SJ, Kim JW, Jeon BS, Singh P, Thierfelder S, Ikeda J, Bauer L; Asia Pacific Rotigotine Add-on Study Group.

BMC Neurol. 2015 Feb 28;15:17. doi: 10.1186/s12883-015-0267-7.

Amyloid deposition in Parkinson's disease and cognitive impairment: a systematic review

Petrou M, Dwamena BA, Foerster BR, MacEachern MP, Bohnen NI, Müller ML, Albin RL, Frey KA.

Mov Disord. 2015 Jun;30(7):928-35. doi: 10.1002/mds.26191. Epub 2015 Apr 16.

Design of the Park-in-Shape study: a phase II double blind randomized controlled trial evaluating the effects of exercise on motor and non-motor symptoms in Parkinson's disease

van der Kolk NM, Overeem S, de Vries NM, Kessels RP, Donders R, Brouwer M, Berg D, Post B, Bloem BR.

BMC Neurol. 2015 Apr 16;15:56. doi: 10.1186/s12883-015-0312-6.

PARP-1 involvement in neurodegeneration: A focus on Alzheimer's and Parkinson's diseases

Martire S, Mosca L, d'Erme M.

Mech Ageing Dev. 2015 Mar;146-148:53-64. doi: 10.1016/j.mad.2015.04.001. Epub 2015 Apr 13.

Emergence of restless legs syndrome after subthalamic stimulation in Parkinson's disease: a dopaminergic overstimulation?

Marques A, Fantini ML, Morand D, Pereira B, Derost P, Ulla M, Debilly B, Lemaire JJ, Durif F.

Sleep Med. 2015 May;16(5):583-8. doi: 10.1016/j.sleep.2014.11.020. Epub 2015 Mar 3.

Linking Smoking, Coffee, Urate, and Parkinson's Disease - A Role for Gut Microbiota?

Scheperjans F, Pekkonen E, Kaakkola S, Auvinen P.

J Parkinsons Dis. 2015;5(2):255-62. doi: 10.3233/JPD-150557.

How Should Pushing Off or the Use of Assistive Devices Be Incorporated in the Timed Up and Go for Persons With Parkinson Disease?

Stegemöller EL, Schmidt P, Hass C, Malaty I, Okun MS; National Parkinson Foundation Quality Improvement Initiative Investigators.

Arch Phys Med Rehabil. 2015 Sep;96(9):1728-32. doi: 10.1016/j.apmr.2015.03.021. Epub 2015 Apr 14.

Inflammation in Parkinson's disease: role of glucocorticoids

Herrero MT, Estrada C, Maatouk L, Vyas S.

Front Neuroanat. 2015 Apr 2;9:32. doi: 10.3389/fnana.2015.00032. eCollection 2015.

Discriminative analysis of Parkinson's disease based on whole-brain functional connectivity

Chen Y, Yang W, Long J, Zhang Y, Feng J, Li Y, Huang B.

PLoS One. 2015 Apr 17;10(4):e0124153. doi: 10.1371/journal.pone.0124153. eCollection 2015.

Adaptive training with full-body movements to reduce bradykinesia in persons with Parkinson's disease: a pilot study

Summa S, Basteris A, Betti E, Sanguineti V.

J Neuroeng Rehabil. 2015 Feb 14;12:16. doi: 10.1186/s12984-015-0009-5.

Capgras delusion for animals and inanimate objects in Parkinson's Disease: a case report

Islam L, Piacentini S, Soliveri P, Scarone S, Gambini O.

BMC Psychiatry. 2015 Apr 8;15:73. doi: 10.1186/s12888-015-0460-7.

Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotection

More SV, Choi DK.

Mol Neurodegener. 2015 Apr 8;10:17. doi: 10.1186/s13024-015-0012-0.

Parkinson's disease dementia: a neural networks perspective

Gratwicke J, Jahanshahi M, Foltynie T.

Brain. 2015 Jun;138(Pt 6):1454-76. doi: 10.1093/brain/awv104. Epub 2015 Apr 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias